Sichuan Kelun Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Sichuan Kelun Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Sichuan Kelun Pharmaceutical Co Ltd (002422) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥537.31 Million ≈ $78.62 Million USD) by net assets (CN¥28.62 Billion ≈ $4.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sichuan Kelun Pharmaceutical Co Ltd (002422) market capitalisation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Cash flow conversion efficiency of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. This chart illustrates how Sichuan Kelun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sichuan Kelun Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.
Sichuan Kelun Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Sichuan Kelun Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Sichuan Kelun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sichuan Kelun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Review free cash flow generation of Sichuan Kelun Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bentley Systems Inc
NASDAQ:BSY
|
0.158x |
|
Shenzhen Transsion Holdings Co Ltd
SHG:688036
|
0.157x |
|
Universal Health Services Inc
NYSE:UHS
|
0.053x |
|
China Merchants Shekou Industrial Zone Holdings
SHE:001979
|
0.019x |
|
WISE PLC SPONS.ADR/1
F:6WS0
|
N/A |
|
Topbuild Corp
NYSE:BLD
|
0.067x |
|
Maplebear Inc.
NASDAQ:CART
|
0.103x |
|
American Healthcare REIT, Inc.
NYSE:AHR
|
0.000x |
Annual Cash Flow Conversion Efficiency for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. Also see Sichuan Kelun Pharmaceutical Co Ltd balance sheet assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥29.29 Billion ≈ $4.29 Billion |
CN¥2.64 Billion ≈ $386.62 Million |
0.090x | -46.32% |
| 2024-12-31 | CN¥26.74 Billion ≈ $3.91 Billion |
CN¥4.49 Billion ≈ $657.45 Million |
0.168x | -27.54% |
| 2023-12-31 | CN¥23.02 Billion ≈ $3.37 Billion |
CN¥5.34 Billion ≈ $780.98 Million |
0.232x | +25.09% |
| 2022-12-31 | CN¥16.87 Billion ≈ $2.47 Billion |
CN¥3.13 Billion ≈ $457.65 Million |
0.185x | -8.00% |
| 2021-12-31 | CN¥14.13 Billion ≈ $2.07 Billion |
CN¥2.85 Billion ≈ $416.62 Million |
0.202x | +27.14% |
| 2020-12-31 | CN¥14.00 Billion ≈ $2.05 Billion |
CN¥2.22 Billion ≈ $324.77 Million |
0.158x | -0.58% |
| 2019-12-31 | CN¥13.91 Billion ≈ $2.03 Billion |
CN¥2.22 Billion ≈ $324.38 Million |
0.159x | -30.12% |
| 2018-12-31 | CN¥12.95 Billion ≈ $1.89 Billion |
CN¥2.95 Billion ≈ $432.19 Million |
0.228x | +127.17% |
| 2017-12-31 | CN¥11.98 Billion ≈ $1.75 Billion |
CN¥1.20 Billion ≈ $176.06 Million |
0.100x | -33.27% |
| 2016-12-31 | CN¥11.47 Billion ≈ $1.68 Billion |
CN¥1.73 Billion ≈ $252.48 Million |
0.150x | +35.54% |
| 2015-12-31 | CN¥11.16 Billion ≈ $1.63 Billion |
CN¥1.24 Billion ≈ $181.37 Million |
0.111x | -0.06% |
| 2014-12-31 | CN¥10.97 Billion ≈ $1.61 Billion |
CN¥1.22 Billion ≈ $178.34 Million |
0.111x | +6.02% |
| 2013-12-31 | CN¥10.02 Billion ≈ $1.47 Billion |
CN¥1.05 Billion ≈ $153.70 Million |
0.105x | +135.82% |
| 2012-12-31 | CN¥9.06 Billion ≈ $1.33 Billion |
CN¥402.77 Million ≈ $58.94 Million |
0.044x | +2.77% |
| 2011-12-31 | CN¥7.93 Billion ≈ $1.16 Billion |
CN¥342.93 Million ≈ $50.18 Million |
0.043x | +104.24% |
| 2010-12-31 | CN¥7.05 Billion ≈ $1.03 Billion |
CN¥149.29 Million ≈ $21.85 Million |
0.021x | -86.66% |
| 2009-12-31 | CN¥1.58 Billion ≈ $231.12 Million |
CN¥250.69 Million ≈ $36.68 Million |
0.159x | -14.55% |
| 2008-12-31 | CN¥1.19 Billion ≈ $174.17 Million |
CN¥221.08 Million ≈ $32.35 Million |
0.186x | -23.77% |
| 2007-12-31 | CN¥691.22 Million ≈ $101.15 Million |
CN¥168.42 Million ≈ $24.65 Million |
0.244x | -- |
About Sichuan Kelun Pharmaceutical Co Ltd
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, ve… Read more